Efficacy and safety of 3‐n‐butylphthalide combined with endovascular treatment in acute ischemic stroke due to large vessel occlusion

BACKGROUND: The drug 3‐n‐butylphthalide (NBP) was developed and approved in China, where it has been used to treat ischemic cerebrovascular diseases. It is also considered to have a neuroprotective effect. This study aimed to evaluate whether NBP combined with endovascular treatment (EVT) can improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shuai, Li, Fengli, Yang, Jie, Xie, Dongjie, Yue, Chengsong, Luo, Weidong, Hu, Jinrong, Song, Jiaxing, Li, Linyu, Huang, Jiacheng, Zhao, Chenhao, Gong, Zili, Yang, Qingwu, Zi, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627349/
https://www.ncbi.nlm.nih.gov/pubmed/36184804
http://dx.doi.org/10.1111/cns.13978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627349/
https://www.ncbi.nlm.nih.gov/pubmed/36184804
http://dx.doi.org/10.1111/cns.13978

Ejemplares similares